Last $2.20 USD
Change Today -0.01 / -0.45%
Volume 135.7K
TSPT On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GM
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas John Dietz Ph.D.

Independent Director, Member of Audit Committee and Member of Compensation Committee, Transcept Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 55 board members in 6 different organizations across 6 different industries.

See Board Relationships
50$207,428

Background*

Dr. Thomas John Dietz, Ph.D serves as the Chairman and Chief Executive Officer of Waypoint Holdings, LLC. Dr. Dietz served as a Co-Chief Executive Officer and Chief Executive Officer of Pacific Growth Equities, LLC. He served as the Head of the Investment Banking Division at Webush until November 2010. He served as Director of Equities Research at an award-winning biotechnology and biopharmaceutical analyst. He has more than 20 years of experience supporting the biopharma ...

Read Full Background

Corporate Headquarters*

1003 West Cutting Boulevard
Point Richmond, California 94804

United States

Phone: 510-215-3500
Fax: --

Board Members Memberships*

Director
Co-Chief Executive Officer, Director, Member of Operations Committee, and Member of Executive Committee
Director
Director
Director
2011-Present
Chairman
2013-Present
Independent Director, Member of Audit Committee and Member of Compensation Committee

Education*

BS
State University of New York
PhD
Washington University, St. Louis

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options22,221
Unexercisable Options22,779
Total Number of Options45,000

Total Compensation*

Total Annual Cash Compensation$33,261
Total Calculated Compensation$207,428
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TSPT:US $2.20 USD -0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kevin C. Gorman Ph.D.Chief Executive Officer, President and Director
Neurocrine Biosciences Inc.
$719.7K
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
€3.0M
Yasuchika Hasegawa Chairman of the Board and Chief Executive Officer
Takeda Pharmaceutical Company Limited
--
Mihael H. Polymeropoulos M.D.Founder, Chief Executive Officer, President and Director
Vanda Pharmaceuticals, Inc.
$515.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TRANSCEPT PHARMACEUTICALS IN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.